Federal Circuit IP Digest
Federal Circuit Clarifies Use of Applicant Admitted Prior Art in Patent Challenges
July 14, 2025
Shockwave Med., Inc. v. Cardiovascular Sys Authored by: Jeremy J. Gustrowsky In the recent case of Shockwave Medical, Inc. v. Cardiovascular Systems, Inc., the Federal Circuit addressed how “Applicant Admitted Prior Art” (AAPA) can be used in patent challenges before…
Read MoreFederal Circuit Upholds Janssen’s Invega Sustenna Patent Against Obviousness Challenge
July 8, 2025
Janssen Pharms., Inc. v. Teva Pharms. USA, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for pharmaceutical patent holders, the Federal Circuit has affirmed the validity of Janssen Pharmaceuticals’ U.S. Patent No. 9,439,906, which covers specific dosing regimens…
Read MoreFederal Circuit Clarifies Obviousness Standards for Drug Dosing Patents
July 8, 2025
Janssen Pharms., Inc. v. Teva Pharms. USA, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit provided important guidance on how courts should analyze the obviousness of pharmaceutical dosing regimen patents. The case involved Janssen’s U.S.…
Read MoreFederal Circuit Affirms Cisco’s Win Over Egenera in Virtual Network Patent Dispute
July 7, 2025
Egenera, Inc. v. Cisco Sys., Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit upheld a district court’s ruling that Cisco Systems, Inc. did not infringe Egenera, Inc.’s U.S. Patent No. 7,231,430, which covers technology for…
Read MoreFederal Circuit Narrows “Consisting Essentially Of” in Eye Therapies v. Slayback Pharma Patent Dispute
June 30, 2025
Eye Therapies, LLC v. Slayback Pharma, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for patent claim interpretation, the Federal Circuit recently reversed a Patent Trial and Appeal Board (PTAB) ruling in Eye Therapies, LLC v. Slayback Pharma,…
Read MoreFederal Circuit Dismisses Realtek’s Appeal Over ITC Sanctions for Lack of Jurisdiction
June 18, 2025
Realtek Semiconductor Corp. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified the limits of its authority to review certain decisions made by the U.S. International Trade Commission (ITC). The case, Realtek…
Read MoreFederal Circuit Vacates PTAB Ruling on Software Patent, Citing Flawed Review of Licensing Deals
June 16, 2025
Ancora Techs., Inc. v. Roku, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit stepped into a patent dispute over technology designed to protect licensed software from unauthorized copying on…
Read MoreApple Wins New Trial in $300 Million LTE Patent Dispute with Optis Over Jury Verdict Form and Damages Evidence
June 16, 2025
Optis Cellular Tech., LLC v. Apple Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent litigation, the Federal Circuit has vacated a $300 million damages award against Apple Inc. in its ongoing dispute with Optis Cellular Technology,…
Read MoreFederal Circuit Affirms Dismissal of Mitek’s Declaratory Judgment Suit Against USAA Over Mobile Banking Patents
June 12, 2025
Mitek Sys. v. United Servs. Auto. Ass’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the dismissal of a declaratory judgment action brought by Mitek Systems, Inc. against United Services Automobile Association (USAA) regarding four…
Read MoreFederal Circuit Strikes Down USAA’s Mobile Check Deposit Patent as Ineligible Abstract Idea
June 12, 2025
United Servs. Auto. Ass’n v. PNC Bank N.A Authored by: Jeremy J. Gustrowsky In a significant decision for financial technology patents, the Federal Circuit reversed a lower court’s ruling and found that United Services Automobile Association’s (USAA) patent on mobile…
Read MoreFederal Circuit Affirms CRISPR Patent Invalidity in Gene Editing Dispute
June 11, 2025
Agilent Techs., Inc. v. Synthego Corp. Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit upheld a ruling that all claims in two patents owned by Agilent Technologies are unpatentable, dealing…
Read MorePatent Owner’s Silence Not Enough: Federal Circuit Revives Fraunhofer’s Patent Suit Against Sirius XM
June 9, 2025
Fraunhofer-Gesellschaft Zur F_rderung Der Angewandten Forschung E.V. v. Sirius XM Radio Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed a district court’s ruling that had blocked Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V. from…
Read More